Please assess the completion status of the following clinical trial:

Trial Title: Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Aged 18 years or above~* Acute stroke due to spontaneous ICH confirmed by clinical history \& CT scan~* At least 2 systolic BP measurements of \>/=150mmHg and \</=220mmHg, recorded 2 or more minutes apart~* Able to commence randomly assigned BP lowering regimen within 6 hours of stroke onset~* Able to be actively treated and admitted to a monitored facility e.g. HDU/ICU/acute stroke unit~Exclusion Criteria:~* Known definite contraindication to an intensive BP lowering regimen~* Known definite indication for intensive BP lowering regimen as (or more) intensive than the active treatment arm~* Definite evidence that the ICH is secondary to a structural abnormality in the brain~* Previous ischaemic stroke within 30 days~* A very high likelihood that the patient will die within the next 24 hours on the basis of clinical and/or radiological criteria~* Known advanced dementia or significant pre-stroke disability~* Concomitant medical illness that would interfere with outcome assessments and follow up~* Already booked for surgical evacuation of haematoma~* Previous participation in this trial or current participation in another investigational drug trial~* A high likelihood that the patient will not adhere to the study treatment and follow up regimen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).